A detailed history of Rebalance, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Rebalance, LLC holds 1,344 shares of JNJ stock, worth $205,954. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,344
Holding current value
$205,954
% of portfolio
0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$145.48 - $167.38 $195,525 - $224,958
1,344 New
1,344 $218 Million
Q4 2022

Feb 27, 2023

BUY
$160.2 - $179.79 $12,976 - $14,562
81 New
81 $14.3 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $401B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Rebalance, LLC Portfolio

Follow Rebalance, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rebalance, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rebalance, LLC with notifications on news.